Sunday, March 31, 2013

At the CRBCM, we keep learning continously!


certifies that
Mutombo Kankonde, MD
2400 Trawood Drive
Suite 303
El Paso, TX 79936
has participated in the enduring material titled

Mechanisms and Actions of HER2-Targeting Agents in Breast Cancer

April 1, 2013
and is awarded 0.50  AMA PRA Category 1 Credit(s)™.
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Certificate Number: 42523061 Cyndi Grimes
Cyndi Grimes
Director, Continuing Medical Education
Medscape, LLC
Options to Her2 positive tumors after Herceptin!
lapatinib +Xeloda
combination with Everolimus Neratinib

Post a Comment